Rampart Investment Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-923
Closed -$158K 298
2020
Q3
$158K Sell
923
-1,755
-66% -$324K 0.1% 202
2020
Q2
$514K Buy
2,678
+1,530
+133% +$250K 0.09% 252
2020
Q1
$169K Sell
1,148
-1,358
-54% -$216K 0.08% 219
2019
Q4
$388K Sell
2,506
-17
-0.7% -$2.45K 0.05% 355
2019
Q3
$341K Sell
2,523
-157
-6% -$20.6K 0.04% 351
2019
Q2
$327K Sell
2,680
-176
-6% -$19.5K 0.04% 371
2019
Q1
$297K Buy
2,856
+1,335
+88% +$138K 0.03% 391
2018
Q4
$173K Sell
1,521
-5,278
-78% -$565K 0.05% 291
2018
Q3
$183K Sell
6,799
-2,232
-25% -$244K 0.08% 265
2018
Q2
$935K Buy
9,031
+3,277
+57% +$332K 0.09% 271
2018
Q1
$567K Buy
5,754
+3,986
+225% +$377K 0.05% 323
2017
Q4
$150K Sell
1,768
-218
-11% -$18K 0.06% 354
2017
Q3
$153K Buy
+1,986
New +$152K 0.05% 378

Other funds holding RMD

Rampart Investment Management's RMD Position: Q4 2020 in Review

Rampart Investment Management sold out of ResMed (RMD) in Q4 2020, closing a stake of 923 shares — an estimated $158K sold.

Rampart Investment Management first reported a position in RMD in Q3 2017 and held it in 13 quarters. The position peaked at $935K in Q2 2018. 664 funds tracked by Wall St. Rank hold RMD as of Q4 2020.

  • Rampart Investment Management reported no remaining ResMed position as of Q4 2020 after selling out during the quarter.
  • Rampart Investment Management sold 923 ResMed shares in Q4 2020, an estimated $158K.
  • Rampart Investment Management first reported a position in ResMed in Q3 2017 and held it in 13 quarters.
  • Rampart Investment Management's ResMed position peaked at $935K in Q2 2018.
  • 664 funds tracked by Wall St. Rank held ResMed as of Q4 2020.

Based on Rampart Investment Management's 13F filing for Q4 2020.